NervGen Pharma Corp. (NGEN)

Last Closing Price: 2.14 (2026-06-22)

Gross Profit (Annual)

Gross Profit: Revenues from operations less the associated costs.

NervGen Pharma Corp. (NGEN) Gross Profit data is not available.

Figures for fiscal year ending 2025-12-31
Income Statement Financials
--
-31.57M
--
Gross Profit
--
17.95M
-17.95M
-13.63M
-31.57M
-31.57M
-31.57M
-31.57M
-31.57M
-31.57M
-17.95M
-17.91M
72.33M
72.33M
-0.44
-0.44
Balance Sheet Financials
16.32M
--
0.29M
16.61M
14.12M
--
--
14.12M
2.49M
2.20M
2.49M
79.65M
Cash Flow Statement Financials
-13.96M
0.07M
17.01M
12.36M
15.80M
3.44M
3.86M
--
--
Fundamental Metrics & Ratios
1.16
--
--
--
0.00
--
--
--
--
--
--
-13.96M
--
--
--
--
--
--
--
-1268.86%
-1438.09%
-190.08%
-1268.86%
0.03
-0.19
-0.19